Tuesday, October 26, 2021

More Errata...

In my post of October 24 I said, "Obviously, Actipulse needs to move ahead with a phase 3 trial."  I should have said, "... move ahead with a phase 2 trial."

No comments:

Post a Comment

Welcome Kisunla

We reported previously that the FDA's advisory panel had recommended approval of the monoclonal antibody treatment donanemab.  This foll...